Ledyard National Bank’s ResMed RMD Stock Holding History

Ledyard National Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-72	Closed	-$4K	–	687
2015 Q2	$4K	Hold	72	–	–	﹤0.01%	630
2015 Q1	$5K	Hold	72	–	–	﹤0.01%	598
2014 Q4	$4K	Hold	72	–	–	﹤0.01%	653
2014 Q3	$4K	Hold	72	–	–	﹤0.01%	625
2014 Q2	$4K	Hold	72	–	–	﹤0.01%	639
2014 Q1	$3K	Buy	+72	New	+$3.23K	﹤0.01%	657

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ledyard National Bank's RMD Position: Q3 2015 in Review

Ledyard National Bank sold out of ResMed (RMD) in Q3 2015, closing a stake of 72 shares — an estimated $4K sold.

Ledyard National Bank first reported a position in RMD in Q1 2014 and held it in 6 quarters. The position peaked at $5K in Q1 2015. 313 funds tracked by Wall St. Rank hold RMD as of Q3 2015.

Ledyard National Bank reported no remaining ResMed position as of Q3 2015 after selling out during the quarter.
Ledyard National Bank sold 72 ResMed shares in Q3 2015, an estimated $4K.
Ledyard National Bank first reported a position in ResMed in Q1 2014 and held it in 6 quarters.
Ledyard National Bank's ResMed position peaked at $5K in Q1 2015.
313 funds tracked by Wall St. Rank held ResMed as of Q3 2015.

Based on Ledyard National Bank's 13F filing for Q3 2015, filed 19 Oct 2015.